Cystitis, Interstitial Clinical Trial
Official title:
A Case Control Study of Interstitial Cystitis
EPIC is a case/control study that seeks to identify the risk factors for interstitial cystitis by comparing the experiences and medical histories of 400 women who recently developed IC with 400 similar people who do not have the disease.
This project is a systematic, national study of incident IC cases and controls matched by
age and gender. By telephone interview and medical record review, we compare exposures of
cases and controls seeking significant differences which may be risk factors for IC. This
cohort of incident IC cases will initiate a natural history study of the disease.
Specific Aim 1. To test the hypothesis that certain features that precede onset of IC
symptoms, e.g., bacterial cystitis, distinguish IC cases from controls matched for age and
gender, and may be risk factors for the disease.
Specific Aim 2. To test the hypotheses that patients with IC have higher prevalences of
certain non bladder syndromes, e.g., irritable bowel syndrome, than do controls matched for
age and gender.
Specific Aim 3. To test the hypothesis that urine APF, HB EGF, and/or EGF are sensitive and
specific diagnostic markers for IC in patients with symptoms of ÿ12 months.
Specific Aim 4. To test the hypotheses that, in an incident cohort, patients with IC have
remissions and that certain clinical features, e.g., bacterial cystitis at disease onset,
are prognostic factors for remissions.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02868775 -
A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
Completed |
NCT00672087 -
Diagnostic Challenges in IC (and Male CPPS)
|
||
Completed |
NCT01482676 -
The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction
|
N/A | |
Completed |
NCT00775281 -
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
|
N/A | |
Terminated |
NCT00380783 -
Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis
|
Phase 2 | |
Completed |
NCT05260112 -
Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide
|
N/A | |
Completed |
NCT05752344 -
Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era
|
||
Completed |
NCT01613586 -
A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
|
Phase 2 | |
Completed |
NCT02411110 -
A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
|
Phase 2 | |
Recruiting |
NCT06299683 -
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
|
N/A | |
Completed |
NCT00601484 -
An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis
|
Phase 2 | |
Completed |
NCT02214550 -
Chronic Pain Risk Associated With Menstrual Period Pain
|
Phase 4 | |
Completed |
NCT04275297 -
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
|
N/A | |
Terminated |
NCT00999518 -
A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome
|
Phase 2 | |
Completed |
NCT00675298 -
Linkage Analysis in Interstitial Cystitis
|
N/A | |
Terminated |
NCT02781103 -
Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT01074567 -
DMSO Efficacy in IC/PBS Patients During and After Treatment
|
N/A | |
Completed |
NCT02497976 -
Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
|
Phase 3 | |
Terminated |
NCT02787083 -
A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis
|
Phase 3 | |
Withdrawn |
NCT00275379 -
Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis
|
N/A |